Molecular Glue DEL Screening to Produce Expansive Datasets for Systematic Hit Identification for High Value Therapeutic Targets
- Development and implementation of a molecular glue DEL screening platform at scale
- Leveraging PPI for targets with high unmet medical need that have proven limited or intractable for ligand finding efforts
- A combination of approaches increases confidence in hit calling for off-DNA synthesis of hits and leads to improved validation